Diabetes 51:S171-S176, 2002
© 2002 by the American Diabetes Association, Inc.
Section 4: Oscillations in ß-Cells |
Role of Oscillations in Membrane Potential, Cytoplasmic Ca2+, and Metabolism for Plasma Insulin Oscillations
Peter Bergsten
From the Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
A model for the relationship between ionic and metabolic oscillations and plasma insulin oscillations is presented. It is argued that the pancreatic ß-cell in vivo displays two intrinsic frequencies that are important for the regulation of plasma insulin oscillations. The rapid oscillatory activity (27 oscillations [osc] per minute), which is evident in both ionic and metabolic events, causes the required elevation in cytoplasmic Ca2+ concentration ([Ca2+]i) for the exocytosis of insulin granules. This activity is important for regulation of the amplitude of plasma insulin oscillations. The frequency of the rapid oscillatory ionic activities is regulated by glucose and allows the ß-cell to respond in an analogous way, with gradual changes in [Ca2+]i and insulin release in response to the alterations in glucose concentration. The slower oscillatory activity (0.20.4 osc/min), which is evident in the metabolism of the ß-cell, has a frequency corresponding to the frequency observed in plasma insulin oscillations. The frequency is not affected by changes in the glucose concentration. This activity is suggested to generate energy in a pulsatile fashion, which sets the frequency of the plasma insulin oscillations. It is proposed that the slow oscillations in [Ca2+]i observed in vitro are a manifestation of the metabolic oscillations and do not represent an in vivo phenomenon.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Zhang, B. Fendler, B. Peercy, P. Goel, R. Bertram, A. Sherman, and L. Satin
Long Lasting Synchronization of Calcium Oscillations by Cholinergic Stimulation in Isolated Pancreatic Islets
Biophys. J.,
November 15, 2008;
95(10):
4676 - 4688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Farhy, Z. Du, Q. Zeng, P. P. Veldhuis, M. L. Johnson, K. L. Brayman, and A. L. McCall
Amplification of pulsatile glucagon counterregulation by switch-off of {alpha}-cell-suppressing signals in streptozotocin-treated rats
Am J Physiol Endocrinol Metab,
September 1, 2008;
295(3):
E575 - E585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Gartner, G. Vila, T. Daneva, A. Nabokikh, F. Koc-Saral, A. Ilhan, O. Majdic, A. Luger, and L. Wagner
New functional aspects of the neuroendocrine marker secretagogin based on the characterization of its rat homolog
Am J Physiol Endocrinol Metab,
July 1, 2007;
293(1):
E347 - E354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Fridlyand, L. Ma, and L. H. Philipson
Adenine nucleotide regulation in pancreatic {beta}-cells: modeling of ATP/ADP-Ca2+ interactions
Am J Physiol Endocrinol Metab,
November 1, 2005;
289(5):
E839 - E848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Nunemaker, R. A. DeFazio, and S. M. Moenter
Calcium Current Subtypes in GnRH Neurons
Biol Reprod,
December 1, 2003;
69(6):
1914 - 1922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Barker, I. B. Leibiger, B. Leibiger, and P.-O. Berggren
Phosphorylated inositol compounds in beta -cell stimulus-response coupling
Am J Physiol Endocrinol Metab,
December 1, 2002;
283(6):
E1113 - E1122.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|